CLL cells exploit the TME, particularly BMSCs, to enhance survival and therapy resistance through AP-1 activation. Core regions in 3D cultures show greater CLL B cell survival and resistance compared ...
A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before. Researchers at NYU Langone Health propose a model that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results